HeartSciences Depreciation & Amortization Growth & History (HSCS)
HeartSciences's depreciation and amortization was $27,791 for fiscal 2026.
View full HeartSciences company overviewHeartSciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $27,791 | −$9,808 | −26.09% |
| 2025 | 2025-04-30 | $37,599 | $9,707 | +34.80% |
| 2024 | 2024-04-30 | $27,892 | $977 | +3.63% |
| 2023 | 2023-04-30 | $26,915 | $349 | +1.31% |
| 2022 | 2022-04-30 | $26,566 | — | — |
HeartSciences quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $34,002 | $2,741 | +8.77% |
| Q3 2026 | 2026-01-31 | $6,916 | $909 | +15.13% |
| Q2 2026 | 2025-10-31 | $7,006 | −$5,209 | −42.64% |
| Q1 2026 | 2025-07-31 | $7,111 | −$4,753 | −40.06% |
| Q4 2025 | 2025-04-30 | $31,261 | — | — |
| Q3 2025 | 2025-01-31 | $6,007 | $2,290 | +61.61% |
| Q2 2025 | 2024-10-31 | $12,215 | $4,579 | +59.97% |
| Q1 2025 | 2024-07-31 | $11,864 | $4,526 | +61.68% |
| Q3 2024 | 2024-01-31 | $3,717 | −$3,148 | −45.86% |
| Q2 2024 | 2023-10-31 | $7,636 | $823 | +12.08% |
| Q1 2024 | 2023-07-31 | $7,338 | $926 | +14.44% |
| Q3 2023 | 2023-01-31 | $6,865 | $369 | +5.68% |
| Q2 2023 | 2022-10-31 | $6,813 | $212 | +3.21% |
| Q1 2023 | 2022-07-31 | $6,412 | −$561 | −8.05% |
| Q3 2022 | 2022-01-31 | $6,496 | — | — |
| Q2 2022 | 2021-10-31 | $6,601 | — | — |
| Q1 2022 | 2021-07-31 | $6,973 | — | — |
HeartSciences depreciation and amortization trends
Between the periods ended 2022-04-30 and 2026-04-30, HeartSciences's depreciation and amortization increased from $26,566 to $27,791, a change of $1,225. The latest reported quarter, Q4 2026, shows $34,002.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences source filings ↗